Home

EDWARD L KUNTZ

CIK 1182168 · Executive Chairman · last filed 2026-05-14

EDWARD L KUNTZ is an Executive Chairman who has filed 77 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing shows the insider bought $29.8K of SLNG on May 14, 2026. Across all open-market trades the lifetime net is −$6.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $586.2K across reported positions. 52 SEC filings were submitted jointly with KINDRED HEALTHCARE, INC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$586.2K

Companies

5

Total Filings

77

Lifetime Open-Market Net

-$6.83M

Filer Profile

Reported Address
11750 KATY FREEWAY
SUITE 900
HOUSTON, TX 77084
Related Filers
KINDRED HEALTHCARE, INC — 52 joint filings, latest 2014-03-26
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
SLNG Director 62,339 $5.32 $331.3K $196.7K 12 2026-05-14
USPH Director 3,280 $77.71 $254.9K -$1.64M 17 2024-05-16
KINDRED HEALTHCARE, INC (KND) Delisted Director 16,054 — — -$5.39M 31 2014-03-26
PharMerica CORP (PMC) Delisted Director 56,832 — — $0 2 2007-08-09
ROTECH HEALTHCARE INC (ROHI) Delisted Director — — — $0 1 2007-07-02

Recent Filings

77 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-05-14 SLNG Buy (P) +7,667 $29.8K EDGAR
2025-02-28 SLNG Buy (P) +4,000 $20.2K EDGAR
2024-05-16 USPH Sell (S) −2,500 -$268.9K EDGAR
2024-05-15 USPH Notice (144) −2,500 -$268.9K EDGAR
2024-03-05 USPH Sell (S) −2,500 -$260.6K EDGAR
2024-03-04 USPH Notice (144) −2,500 -$260.7K EDGAR
2023-11-14 SLNG Buy (P) +5,000 $24.6K EDGAR
2023-08-14 USPH Notice (144) −1,000 -$107.7K EDGAR
2023-08-14 USPH Sell (S) −2,000 -$217.6K EDGAR
2023-08-11 USPH Notice (144) −1,000 -$110.1K EDGAR
Showing 1–10 of 77
Page 1 of 8
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.